A SARS-CoV-2 protein interaction map reveals targets for drug repurposing DE Gordon, GM Jang, M Bouhaddou, J Xu, K Obernier, KM White, ... Nature 583 (7816), 459-468, 2020 | 4303 | 2020 |
The global phosphorylation landscape of SARS-CoV-2 infection M Bouhaddou, D Memon, B Meyer, KM White, VV Rezelj, MC Marrero, ... Cell 182 (3), 685-712. e19, 2020 | 855 | 2020 |
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms DE Gordon, J Hiatt, M Bouhaddou, VV Rezelj, S Ulferts, H Braberg, ... Science 370 (6521), eabe9403, 2020 | 598 | 2020 |
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling L Miorin, T Kehrer, MT Sanchez-Aparicio, K Zhang, P Cohen, RS Patel, ... Proceedings of the National Academy of Sciences 117 (45), 28344-28354, 2020 | 464 | 2020 |
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A KM White, R Rosales, S Yildiz, T Kehrer, L Miorin, E Moreno, S Jangra, ... Science 371 (6532), 926-931, 2021 | 289 | 2021 |
COVID-19: famotidine, histamine, mast cells, and mechanisms RW Malone, P Tisdall, P Fremont-Smith, Y Liu, XP Huang, KM White, ... Frontiers in Pharmacology 12, 633680, 2021 | 146 | 2021 |
Increased replicative fitness can lead to decreased drug sensitivity of Hepatitis C virus DEPC Sheldon J, Beach NM, Moreno E, Gallego I, Piñeiro D, Martínez-Salas E ... Journal of Virology 88 (20), 12098-12111, 2014 | 81 | 2014 |
Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture K Bafna, K White, B Harish, R Rosales, TA Ramelot, TB Acton, E Moreno, ... Cell reports 35 (7), 2021 | 59 | 2021 |
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment. PC Moreno E, Gallego I, Gregori J, Lucía-Sanz A, Soria ME, Castro V, Beach ... J Virol. 91, 2017 | 42 | 2017 |
Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus. PC Gallego I, Sheldon J, Moreno E, Gregori J, Quer J, Esteban JI, Rice CM ... Antimicrob Agents Chemother. 60, 2016 | 42 | 2016 |
Favipiravir can evoke lethal mutagenesis and extinction of foot-and-mouth disease virus. DE de Avila AI, Moreno E, Perales C Virus Res. 233, 2017 | 34 | 2017 |
Multifunctionality of a picornavirus polymerase domain: nuclear localization signal and nucleotide recognition C Ferrer-Orta, I de la Higuera, F Caridi, MT Sánchez-Aparicio, E Moreno, ... Journal of Virology 89 (13), 6848-6859, 2015 | 31 | 2015 |
Exploration of sequence space as the basis of viral RNA genome segmentation DEPC Moreno E, Ojosnegros S, García-Arriaza J, Escarmís C PNAS 111 (18), 6678-6683, 2014 | 25* | 2014 |
Clonality and intracellular polyploidy in virus evolution and pathogenesis C Perales, E Moreno, E Domingo Proceedings of the National Academy of Sciences 112 (29), 8887-8892, 2015 | 19 | 2015 |
Metabolic snapshot of plasma samples reveals new pathways implicated in SARS-CoV-2 pathogenesis OE Albóniga, D Jiménez, M Sánchez-Conde, P Vizcarra, R Ron, ... Journal of Proteome Research 21 (3), 623-634, 2022 | 14 | 2022 |
Synergistic lethal mutagenesis of hepatitis C virus I Gallego, ME Soria, J Gregori, AI de Ávila, C García-Crespo, E Moreno, ... Antimicrobial Agents and Chemotherapy 63 (12), 10.1128/aac. 01653-19, 2019 | 12 | 2019 |
CD4/CD8 ratio during human immunodeficiency virus treatment: time for routine monitoring? R Ron, E Moreno, J Martínez-Sanz, F Brañas, T Sainz, S Moreno, ... Clinical Infectious Diseases 76 (9), 1688-1696, 2023 | 10 | 2023 |
Similar CD4/CD8 ratio recovery after initiation of dolutegravir plus lamivudine versus dolutegravir or bictegravir-based three-drug regimens in naive adults with HIV J Martínez-Sanz, R Ron, E Moreno, M Sánchez-Conde, A Muriel, ... Frontiers in immunology 13, 873408, 2022 | 9 | 2022 |
Hepatitis C Virus drugs simeprevir and grazoprevir synergize with remdesivir to suppress SARS-CoV-2 replication in Cell Culture K Bafna, K White, B Harish, R Rosales, TA Ramelot, TB Acton, E Moreno, ... BioRxiv, 2020.12. 13.422511, 2020 | 8 | 2020 |
Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2 D Jiménez, J Martínez-Sanz, T Sainz, C Calvo, A Méndez-Echevarría, ... Journal of Infection 85 (1), 86-89, 2022 | 7 | 2022 |